CannaXan GmbH
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Trial on Pharmacokinetics and Tolerability of AP707 (NCT05267769) | CannaXan GmbH | 2022-03-02 |
| Clinical Trial on Pharmacokinetic and Tolerability of AP701 (NCT04708795) | CannaXan GmbH | 2020-01-11 |
Track CannaXan GmbH automatically
Every clearance here is in the API, with alerts when new ones post.